Studies have proven the NonHDLc/HDLc ratio to be a better predictor for CVD than NonHDLc [23], as well as a better predictor for insulin resistance and MS than the apoB/apoA1 ratio (difference might be attributed to dysfunctional HDL levels). The gene discussed is APOB; the disease is Insulin resistance.